These results demonstrated that GDC-0941 inhibited the phosphorylation of AKT, S6, and p70S6K, and ILK influenced the sensitivity of breast cancer cells to GDC-0941 by affecting AKT expression. This evidence concerns the gene RPS6KB1 and breast carcinoma.